Literature DB >> 30879339

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Donna K Arnett, Roger S Blumenthal, Michelle A Albert1, Andrew B Buroker2, Zachary D Goldberger3, Ellen J Hahn1, Cheryl Dennison Himmelfarb1, Amit Khera1, Donald Lloyd-Jones1, J William McEvoy1, Erin D Michos1, Michael D Miedema1, Daniel Muñoz1, Sidney C Smith1, Salim S Virani1, Kim A Williams1, Joseph Yeboah1, Boback Ziaeian4.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; LDL cholesterol; antihypertensive agents; aspirin; atherosclerosis; atherosclerotic cardiovascular disease; atrial fibrillation; behavior modification; behavior therapy; blood cholesterol; blood pressure; body mass index; cardiovascular; cardiovascular disease; cardiovascular team-based care; cholesterol; chronic kidney disease; coronary artery calcium score; coronary disease; coronary heart disease; cost; diabetes mellitus; diet; dietary fats; dietary patterns; dietary sodium; dyslipidemia; e-cigarettes; exercise; guidelines; health services accessibility; healthcare disparities; heart failure; hypertension; lifestyle; lipids; measurement; myocardial infarction; nicotine; nonpharmacological treatment; nutrition; physical activity; prejudice; primary prevention; psychosocial deprivation; public health; quality indicators; quality measurement; risk assessment; risk factors; risk reduction; risk reduction discussion; risk treatment discussion; risk-enhancing factors; secondhand smoke; sleep; smoking; smoking cessation; social determinants of health; socioeconomic factors; statin therapy; systems of care; tobacco; tobacco smoke pollution; treatment adherence; treatment outcomes; type 2 diabetes mellitus; waist circumference; weight loss

Mesh：

Year:  2019        PMID： 30879339      PMCID： PMC8351755          DOI： 10.1161/CIR.0000000000000677

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  267 in total

Review 1.  Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.

Authors:  Costas Thomopoulos; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2014-12       Impact factor: 4.844

2.  Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States.

Authors:  Michelle C Odden; Mark J Pletcher; Pamela G Coxson; Divya Thekkethala; David Guzman; David Heller; Lee Goldman; Kirsten Bibbins-Domingo
Journal:  Ann Intern Med       Date:  2015-04-21       Impact factor: 25.391

3.  Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

Authors:  Peter S Sever; Neil R Poulter; Björn Dahlöf; Hans Wedel; Rory Collins; Gareth Beevers; Mark Caulfield; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

4.  Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.

Authors:  Jan D Hirsch; Neil Steers; David S Adler; Grace M Kuo; Candis M Morello; Megan Lang; Renu F Singh; Yelena Wood; Robert M Kaplan; Carol M Mangione
Journal:  Clin Ther       Date:  2014-07-30       Impact factor: 3.393

Review 5.  Addressing sleep disturbances: an opportunity to prevent cardiometabolic disease?

Authors:  Michael A Grandner
Journal:  Int Rev Psychiatry       Date:  2014-04

6.  Predicting the 30-year risk of cardiovascular disease: the framingham heart study.

Authors:  Michael J Pencina; Ralph B D'Agostino; Martin G Larson; Joseph M Massaro; Ramachandran S Vasan
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

7.  Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials.

Authors:  J M Geleijnse; F J Kok; D E Grobbee
Journal:  J Hum Hypertens       Date:  2003-07       Impact factor: 3.012

8.  Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.

Authors:  Linnea A Polgreen; Jayoung Han; Barry L Carter; Gail P Ardery; Christopher S Coffey; Elizabeth A Chrischilles; Paul A James
Journal:  Hypertension       Date:  2015-11-02       Impact factor: 10.190

9.  Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969-2020.

Authors:  Hannah K Weir; Robert N Anderson; Sallyann M Coleman King; Ashwini Soman; Trevor D Thompson; Yuling Hong; Bjorn Moller; Steven Leadbetter
Journal:  Prev Chronic Dis       Date:  2016-11-17       Impact factor: 2.830

Review 10.  Built Environment, Selected Risk Factors and Major Cardiovascular Disease Outcomes: A Systematic Review.

Authors:  Pasmore Malambo; Andre P Kengne; Anniza De Villiers; Estelle V Lambert; Thandi Puoane
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240
View more
  136 in total

1.  Regulation of calcific vascular and valvular disease by nuclear receptors.

Authors:  Tamer Sallam; Yin Tintut; Linda L Demer
Journal:  Curr Opin Lipidol       Date:  2019-10       Impact factor: 4.776

Review 2.  Nonalcoholic Fatty Liver Disease and Cardiovascular Disease.

Authors:  Eric M Przybyszewski; Giovanni Targher; Michael Roden; Kathleen E Corey
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-02-01

3.  Mind the Gap: Statin Underutilization and Impact on Mortality in Liver Transplant Recipients.

Authors:  Patrick T Campbell; Lisa B VanWagner
Journal:  Liver Transpl       Date:  2019-10       Impact factor: 5.799

4.  Identification of High-Risk Left Ventricular Hypertrophy on Calcium Scoring Cardiac Computed Tomography Scans: Validation in the DHS.

Authors:  Fernando U Kay; Suhny Abbara; Parag H Joshi; Sonia Garg; Amit Khera; Ronald M Peshock
Journal:  Circ Cardiovasc Imaging       Date:  2020-02-18       Impact factor: 7.792

Review 5.  ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research.

Authors:  Joyonna Carrie Gamble-George; Christopher T Longenecker; Allison R Webel; David H Au; Arleen F Brown; Hayden Bosworth; Kristina Crothers; William E Cunningham; Kevin A Fiscella; Alison B Hamilton; Christian D Helfrich; Joseph A Ladapo; Amneris Luque; Jonathan N Tobin; Gail E Wyatt
Journal:  Prog Cardiovasc Dis       Date:  2020-03-19       Impact factor: 8.194

6.  Cardiovascular benefits of SGLT2 inhibitors in patients with heart failure: a meta-analysis of small and large randomized controlled trials.

Authors:  Saeed Shoar; Ahmed Ali Shah; Waleed Ikram; Najam Farooq; Agnes Udoh; Elsa Tabibzadeh; Soheila Khavandi; Siamak Khavandi
Journal:  Am J Cardiovasc Dis       Date:  2021-06-15

7.  Hemorrhage Risk Profiles among Different Antithrombotic Regimens: Evidence from a Real-World Analysis of Postmarketing Surveillance Data.

Authors:  Xue Sun; Bi Ze; Ling-Jun Zhang; Yang-Zhong BaiMa; Wei Zuo; Bin Zhao; Luo-Bo GeSang
Journal:  Cardiovasc Drugs Ther       Date:  2020-11-23       Impact factor: 3.727

8.  Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The MESA Study (Multi-Ethnic Study of Atherosclerosis).

Authors:  Miguel Cainzos-Achirica; Michael D Miedema; John W McEvoy; Mahmoud Al Rifai; Philip Greenland; Zeina Dardari; Matthew Budoff; Roger S Blumenthal; Joseph Yeboah; Daniel A Duprez; Martin Bødtker Mortensen; Omar Dzaye; Jonathan Hong; Khurram Nasir; Michael J Blaha
Journal:  Circulation       Date:  2020-04-01       Impact factor: 29.690

9.  Relationship between dietary sodium and sugar intake: A cross-sectional study of the National Health and Nutrition Examination Survey 2001-2016.

Authors:  Todd W Gress; Kanaan Mansoor; Yaser M Rayyan; Rodhan A Khthir; Reema F Tayyem; Antonios H Tzamaloukas; Nader G Abraham; Joseph I Shapiro; Zeid J Khitan
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738

10.  Sleep and cardiovascular outcomes in relation to nocturnal hypertension: the J-HOP Nocturnal Blood Pressure Study.

Authors:  Kazuomi Kario; Satoshi Hoshide; Michiaki Nagai; Yukie Okawara; Hiroshi Kanegae
Journal:  Hypertens Res       Date:  2021-07-30       Impact factor: 3.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.